Search results
Kansas sues Pfizer, saying it misled the public over COVID-19 vaccine
Market Watch· 17 hours agoThe state of Kansas has filed a lawsuit against Pfizer alleging the company misled the public about...
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 1 day agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19 vaccine for the 2024-2025 fall season...
Kansas sues Pfizer over COVID vaccine for what Kris Kobach calls 'misleading marketing'
The Topeka Capital-Journal via Yahoo News· 1 day agoKobach cited a study on rats injected with full doses of the COVID vaccine and a collection of...
Gateway - Quartz
Quartz· 1 hour agoThe World Health Organization (WHO) declared covid-19 a pandemic three years ago, on Mar. 11, 2020. The declaration has not lapsed, and though most cases are mild, more than ...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 5 days agoNovavax stock rocketed to a nearly two-year high in June, thanks to a $1.3 billion deal and the...
Fact Check: Study does not say COVID vaccines may have fuelled excess deaths
Reuters· 6 days agoA newly released study does not say COVID-19 vaccines may have fuelled excess deaths across the...
New COVID-19 strain KP.3 circulating in US. What is the situation in Riverside County?
The Desert Sun· 4 days agoA new COVID-19 variant called KP.3 is on the rise in the United States and has been detected in...
FDA modifies strain recommendation for fall COVID vaccine amid variant shifts, uptick in cases
Center for Infectious Disease Research and Policy· 4 days agoShortly after, the FDA accepted the advisers' advice but said it would continue to monitor the...
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA TODAY via Yahoo News· 5 days agoIn general, the agency says, people with COVID-19 have a wide range of symptoms, ranging from mild to severe illness. Symptoms may appear two to 14 days after exposure. < ...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 4 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...